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Hypoxia ameliorates intestinal inﬂammation
through NLRP3/mTOR downregulation and
autophagy activation
Jesus Cosin-Roger1, Simona Simmen1, Hassan Melhem1, Kirstin Atrott1, Isabelle Frey-Wagner1,
Martin Hausmann1, Cheryl de Vallière1, Marianne R. Spalinger1, Patrick Spielmann2,3, Roland H. Wenger2,3,
Jonas Zeitz1, Stephan R. Vavricka1, Gerhard Rogler1,3 & Pedro A. Ruiz1
Hypoxia regulates autophagy and nucleotide-binding oligomerization domain receptor, pyrin
domain containing (NLRP)3, two innate immune mechanisms linked by mutual regulation
and associated to IBD. Here we show that hypoxia ameliorates inﬂammation during the
development of colitis by modulating autophagy and mammalian target of rapamycin
(mTOR)/NLRP3 pathway. Hypoxia signiﬁcantly reduces tumor necrosis factor α, interleukin
(IL)-6 and NLRP3 expression, and increases the turnover of the autophagy protein p62 in
colon biopsies of Crohn’s disease patients, and in samples from dextran sulfate sodium-
treated mice and Il-10−/− mice. In vitro, NF-κB signaling and NLRP3 expression are reduced
through hypoxia-induced autophagy. We also identify NLRP3 as a novel binding partner of
mTOR. Dimethyloxalylglycine-mediated hydroxylase inhibition ameliorates colitis in mice,
downregulates NLRP3 and promotes autophagy. We suggest that hypoxia counteracts
inﬂammation through the downregulation of the binding of mTOR and NLRP3 and activation
of autophagy.
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Crohn’s disease (CD) and ulcerative colitis (UC), the mainclinical phenotypes of inﬂammatory bowel diseases (IBD),are complex diseases arising from the interplay between
genetic and environmental factors that inﬂuence mucosal
homeostasis and trigger an inappropriate immune response1, 2. In
recent years, environmental hypoxia has been increasingly
recognized as an important environmental factor inﬂuencing the
development of IBD3, 4. Because of the integral role of the
epithelium in maintaining intestinal homeostasis, intestinal
epithelial cells (IECs) have evolved many molecular mechanisms
to cope with ﬂuctuations in blood ﬂow, oxygen availability and
metabolism, resulting in tissue hypoxia, particularly during the
severe shifts associated with active inﬂammation in IBD5, 6.
Adaptive transcriptional responses to oxygen deprivation are
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Fig. 1 Hypoxia reduces inﬂammatory gene expression and induces autophagy ﬂux in CD patients. a, b, c, d, e, and f Healthy volunteers (HV, n= 10), patients
with Crohn’s disease (CD, n= 11) and patients with ulcerative colitis (UC, n= 9) were subjected to hypoxic conditions in a hypobaric chamber simulating an
altitude of 4000m.a.s.l. for 3 h. Distal colon biopsies were taken the day before entering the hypobaric chamber (T0), immediately after hypoxia (T1), and
1 week after collection of the ﬁrst biopsy (T2), and transcript analysis was performed. Statistical analysis was performed using one-way ANOVA followed
by Tukey’s post-test. Results represent mean + s.e.m.,*P< 0.05; **P< 0.01; ***P< 0.001; ns= not signiﬁcant. g Immunostaining for p62 (arrowheads) was
performed on distal colon sections and immunohistochemistry (IHC) score was determined by two independent, blinded investigators. Scale bar, 25 µm
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mediated mainly through the hypoxia inducible factor (HIF)
complexes, which are tightly regulated through the action of three
prolylhydroxylases and one asparagine hydroxylase7. In steady
state conditions, hydroxylases suppress the activity of HIF
through the hydroxylation of Pro402 and Pro564 of HIF-1α,
leading to ubiquitination and proteasomal degradation8. A fur-
ther hydroxylation of Asn803 prevents HIF transcriptional
activity. Hypoxia, blocks these processes, allowing HIF-1α to
accumulate and induce the expression of HIF target genes9. Both
HIF-1α and HIF-2α are induced in the inﬂamed mucosa from
IBD patients and mouse models of colitis10, 11, and promote
epithelial barrier function and the resolution of inﬂammation in
various mouse models of disease5, 12, 13. Hypoxia activates further
innate immune protective mechanisms such as autophagy. Thus,
HIF-1α induces the expression of several autophagosome mar-
kers, including LC3, autophagy related gene (ATG)5 and beclin-1,
as well as the conversion of LC3-I to LC3-II14.
Functional polymorphisms in gene loci, including autophagy
proteins such as ATG16L1, IRGM, and nucleotide-binding oli-
gomerization domain-containing protein (NOD)2 are associated
with an increased risk of CD, suggesting defective autophagy in
the pathogenesis of IBD15, 16. Autophagy ensures energetic
homeostasis in cells by providing nutrients during metabolic
stress and also serves a protective role by removing damaged
components from the cytosol17. Autophagic adaptor proteins,
such as p62 (also known as SQSTM1/sequestosome 1), deliver
target substrates for degradation to the autophagosome via
binding to the microtubule-associated protein 1 light chain 3
(LC3)18. LC3 is linked to phosphatidylethanolamine, yielding a
product known as LC3-II19, which remains associated with
autophagosomes until its destruction. Thus, the amount of
membrane-bound LC3-II provides a good index of autophagy
induction20. Environmental stress induces autophagy through the
inhibition of mammalian target of rapamycin (mTOR), a serine/
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Fig. 2 Hypoxia reduces inﬂammatory processes and induces autophagy in the DSS mouse model of colitis. a, b, c, d, e, f and gWT and Nrlp3−/− mice were
administered with DSS or DSS-free water and subjected to normoxia (N, 21% O2) or hypoxia (H, 8% O2). After 18 h, mice were killed and colon biopsies
were collected. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-test. Results represent mean + s.e.m., WT mice under
normoxia: n= 5, WT mice under normoxia: n= 5, DSS-treated WT mice under normoxia: n= 6; Nrlp3−/− mice under normoxia: n= 5; DSS-treated Nrlp3−/−
mice under normoxia: n= 6; WT mice under hypoxia: n= 4, DSS-treated WT mice under hypoxia: n= 5; Nrlp3−/− mice under hypoxia: n= 3; DSS-treated
Nrlp3−/− mice under hypoxia: n= 3, *P< 0.05; **P< 0.01; ***P< 0.001. h Total protein was isolated and western blot performed. LC3-I and LC3-II bands
were quantiﬁed, and autophagy was measured by variations in the ratio of LC3-II/LC3-I and the total amount of LC3 (LC3-I plus LC3-II) relative to β-actin
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threonine protein kinase that belongs to the phosphatidylinositol
3-kinase-related kinase family21, 22. Hypoxia inhibits mTOR
signaling through HIF-1-dependent and -independent mechan-
isms, as well as through proteins that prevent the binding of
mTOR with the mTOR upstream activator Ras homolog enriched
in brain (RHEB)23. Despite recent efforts, the molecular
mechanisms underlying the induction of autophagy in response
to hypoxia remain incompletely understood.
Hypoxia has also been associated with the activation of NOD-
like receptor, pyrin domain-containing (NLRP)3. NLRP3 is best
known as a component of the inﬂammasome, a multiprotein
signaling complex responsible for the activation of caspase-1 and
subsequent maturation of pro-interleukin (IL)-1β and pro-IL-18
that can be activated by a wide range of stimuli, like adenosine
triphosphate (ATP)24, reactive oxygen species (ROS)25, and
inorganic materials26, 27. NLRP3 and the inﬂammasome path-
ways play a decisive role in maintaining intestinal homeostasis,
and single-nucleotide polymorphisms in the NLRP3 gene have
recently been associated with the development of CD28.
Accumulating evidence indicates that NLRP3 and autophagy
pathways are linked by reciprocal regulation, and recent studies
have shown autophagy-dependent degradation of NLRP329, 30.
Our results identify NLRP3 as a binding partner of mTOR, and
show that environmental hypoxia ameliorates intestinal inﬂam-
mation through the reduction of NLRP3 and mTOR binding, and
the subsequent activation of autophagy.
Results
Hypoxia reduces inﬂammatory gene expression in CD patients.
To study the effects of hypoxia on colonic inﬂammatory path-
ways, healthy subjects and patients with IBD in clinical remission
were subjected to hypoxic conditions, resembling an altitude of
4000 m above sea level (m.a.s.l.) for 3 h. Transcriptional analysis
of distal colon biopsies from patients with CD, but not UC,
evidenced increased levels of NLRP3 and tumor necrosis factor
(TNF)α, but not IL-1β or IL-6 mRNA prior to hypoxia
(Fig. 1a–d). Hypoxia signiﬁcantly reduced the mRNA expression
of TNFα (Fig. 1a), IL-6 (Fig. 1c) and NLRP3 (Fig. 1d)
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Fig. 3 Hypoxia reduces inﬂammatory processes and induces autophagy in Il-10−/− mice. a, b, c, d, e, f and g WT, Nrlp3−/−,Il-10−/−, and
Il-10−/−Nrlp3−/−double knockout mice were subjected to normoxia (N, 21% O2) or hypoxia (H, 8% O2). After 18 h, mice were killed and colon biopsies were
collected. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-test. Results represent mean + s.e.m., WT mice
under normoxia: n= 5, WT mice under hypoxia: n= 5; Nrlp3−/− mice under normoxia: n= 4; Nrlp3−/− mice under hypoxia: n= 5; Il-10−/− mice under
hypoxia: n= 4; Il-10−/− mice under hypoxia: n= 4; Il-10−/−Nrlp3−/− mice under normoxia: n= 7; Il-10−/−Nrlp3−/− mice under hypoxia: n= 9, *P< 0.05;
**P< 0.01; ***P< 0.001. h Total protein was isolated and western blot performed. LC3-I and LC3-II bands were quantiﬁed, and autophagy was measured by
variations in the ratio of LC3-II/LC3-I and the total amount of LC3 (LC3-I plus LC3-II) relative to β-actin
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immediately after hypoxia, and this reduction was still evident
1 week later. Interestingly, hypoxia downregulated inﬂammatory
gene expression concomitantly with the induction of autophagy-
associated p62 (Fig. 1e), but not LC3 (Fig. 1f). Although histology
samples did not show any differences in the inﬂammatory status
of patients with IBD prior to or after hypoxia, immunostaining
for p62 of distal colon sections showed a trend towards reduced
protein levels of p62 1 week after hypoxia in HV and patients
with CD, indicating a hypoxia-mediated increase in autophagy
ﬂux (Fig. 1g, arrowheads).
Hypoxia reduces DSS-induced inﬂammatory gene expression.
To further study the inﬂuence of hypoxia in inﬂammation, and
the role of NLRP3 in hypoxia-mediated effects, WT and Nlrp3−/−
mice were administered with 2% dextran sulfate sodium (DSS)
for 7 days in drinking water and subjected to normoxia or
hypoxia for 18 h. DSS-treated WT and Nlrp3−/− mice presented
increased mRNA expression of proinﬂammatory mediators,
including Tnfα, Il-6, Il-1β, and Nlrp3 (Fig. 2a–d). Hypoxia sig-
niﬁcantly reduced Tnfα, Il-6, Il-1β, and Nlrp3 mRNA levels in
WT mice, but not Nlrp3−/− mice (Fig. 2a–d), supporting a role
for NLRP3 in hypoxia-mediated inhibitory effects. Hypoxia also
induced the expression of the autophagy proteins p62 and Lc3 in
both WT and Nlrp3−/− mice (Fig. 2f and g). Hypoxic conditions
were conﬁrmed through the induction of the hypoxia marker
vascular endothelial growth factor (Vegf) (Fig. 2e). Under nor-
moxia, DSS-treated mice presented increased levels of
phosphorylated NF-κB subunit p65/RelA concomitantly with p62
accumulation (Fig. 2h and Supplementary Fig. 1A). In WT mice,
hypoxia reversed DSS-induced p65/RelA phosphorylation and
NLRP3 expression, and restored autophagy as evidenced by the
reduction of mTOR phosphorylation and degradation of p62,
as well as the increase of the ratio LC3-II/LC3-I and LC3
degradation (Fig. 2h and Supplementary Fig. 1B–D). Interest-
ingly, Nlrp3−/− mice showed reduced levels of phosphorylated
mTOR when compared to WT mice as well as impaired responses
to hypoxia evidenced by the lack of marked changes in the ratio
LC3-II/LC3-I and LC3 degradation (Fig. 2h and Supplementary
Fig. 1C, D), suggesting a role for NLRP3 in the control of
autophagy.
Hypoxia blocks inﬂammatory gene expression in Il-10−/−mice.
Next, we sought to conﬁrm the anti-inﬂammatory effects of
hypoxia in the Il-10−/− mouse model of colitis. WT, Il-10−/−,
Nlrp3−/−, and Il-10−/−Nlrp3−/− double knockout mice were
subjected to normoxia or hypoxia for 18 h prior to colon biopsy
collection. Under normoxic conditions, Il-10−/− mice presented
increased mRNA levels of Tnfα, Il-6, Il-1β and Nlrp3, which
were signiﬁcantly reduced under hypoxia (Figs. 3a–d), together
with the induction of p62 expression (Fig. 3f). Although not-
signiﬁcant, our results also show a clear trend towards an increase
in the mRNA levels of Lc3 under hypoxia (Fig. 3g). Under nor-
moxia, Il-10−/− mice also presented an increased accumulation
of phosphorylated p65/RelA, phosphorylated mTOR, p62 and
VEGF
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LC3 compared to Il-10−/− NLRP3−/− mice (Fig. 3h and Supple-
mentary Fig. 2A, C–E), suggesting a blockage of autophagy pro-
moted by NLRP3 concomitantly with the induction of the NF-κB
signaling pathway. Conversely, and in line with our results in the
DSS mouse model, hypoxia reduced NLRP3 expression and p65/
RelA phosphorylation, and restored autophagy as evidenced by
the reduction of phosphorylated mTOR, the increase of the ratio
LC3-II/LC3-I and subsequent degradation of LC3 and p62
(Fig. 3h and Supplementary Fig. 2A–E).
Hypoxia induces NLRP3 degradation and autophagy in IECs.
Since our results in patients with CD and the DSS and Il-10−/−
mouse models of colitis suggest a protective effect of hypoxia in
the colonic mucosa linked to the reduction of NLRP3 and the
activation of autophagy, we sought to elucidate the molecular
mechanisms governing the regulation of these pathways in IECs.
For this purpose, we subjected the human IEC line HT-29 to
hypoxia in the presence and absence of lipopolysaccharide (LPS).
HIF-1α protein accumulation peaked after 6 h of hypoxia (Fig. 4a
and Supplementary Fig. 3A). In line with our results in mice,
constitutive phosphorylation of NF-κB subunit p65/RelA and the
NF-κB upstream inhibitor IκBα was reversed under hypoxia in a
time-dependent manner (Fig. 4a and Supplementary Fig. 3B, C).
Hypoxia also activated autophagy, as evidenced by the reduction
of the phosphorylation/activation of mTOR, the conversion of
LC3-I into LC3-II, and the subsequent degradation of p62 and
LC3 protein (Fig. 4a and Supplementary Fig. 3E–G). Interestingly,
hypoxia also reduced constitutive and LPS-induced protein
expression of NLRP3 (Fig. 4a and Supplementary Fig. 3D). In
accordance with our in vivo results, hypoxia triggered p62 mRNA
expression (Fig. 4b). Likewise, hypoxia induced a transient
expression of NLRP3 mRNA after 6 and 18 h, which returned to
basal levels after 24 h of hypoxia (Fig. 4c), indicating that NLRP3
protein expression was not due to a reduction in the levels of
NLRP3 mRNA. Protein levels of NLRP3 were also reduced in the
presence of the proteasome inhibitor MG132, revealing that
hypoxia induces NLRP3 clearance through a proteasome-
independent mechanism (Fig. 4e and Supplementary Fig. 3H).
Interestingly, hypoxia reversed the accumulation of ubiquitinated
proteins in the presence of the proteasome inhibitor, pointing to
the activation of alternative protein degradation mechanisms
under hypoxia such as autophagy (Fig. 4e).
Following our results on hypoxia-mediated regulation of p62
and NLRP3 expression, we sought to elucidate the molecular
mechanisms governing the transcriptional regulation of both
genes. Sequence analysis of the p62 promoter identiﬁed putative
binding sites for HIF-1α and p65/RelA at −234 and +42,
respectively (Fig. 4f). One putative binding site for p65/RelA
was also found at −468 and one binding site for HIF-1α at −150
in the NLRP3 promoter (Fig. 4g). To investigate the binding
activity of both transcription factors to the p62 and NLRP3
promoters in HT-29 cells subjected to hypoxia (0.2 % O2, 6 and
24 h), chromatin immunoprecipitation (ChIP) analysis was
performed. In line with the stabilization of HIF-1α after 6 h of
hypoxia, ChIP analysis shows increased biding of HIF-1α to the
promoter of p62 after 6 h of hypoxia compared to normoxia,
suggesting a role for HIF-1α in the induction of p62 expression
observed under low oxygen level conditions (Fig. 4f). In
accordance with the reduction in p65/RelA phosphorylation
under hypoxia, binding of NF-κB to the p62 promoter was not
induced at low oxygen levels (Fig. 4g). In contrast, and in line
with the constitutive expression of NLRP3 in unstimulated cells,
we observed constitutive binding of NF-κB to the NLRP3
b
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promoter. Of note, HIF-1α was not found in the promoter of
NLRP3 despite the accumulation of HIF-1α observed during
hypoxia (Fig. 4g).
Hypoxia-mediated autophagy reduces NF-κB signaling in
IECs. Biosynthesis and accumulation of lysosomes in HT-29 cells
under hypoxia was monitored using LysoTracker Yellow-HCK-
123, a ﬂuorescence probe that accumulates in acidic organelles
such as lysosomes. Hypoxia induced the accumulation of lyso-
somes, further conﬁrming the induction of autophagy at low
oxygen levels. Active mitochondria monitored using MitoTracker
Deep Red FM were not affected after 24 h of hypoxia (Fig. 5a). In
order to clarify the causality between hypoxia-mediated autop-
hagy and the reduction of inﬂammatory processes, HT-29 cells
were subjected to hypoxia in the presence of chloroquine, a late-
stage autophagy inhibitor that prevents the fusion of autopha-
gosome with lysosome. As expected, autophagy was induced 24 h
after hypoxia as demonstrated by a signiﬁcant increase in staining
for LC3 (green) in the presence of chloroquine (Fig. 5b).
Hypoxia-induced p62 degradation was blocked in the presence of
chloroquine, as well as the reduction of phosphorylated p65/RelA
(Fig. 5c and Supplementary Fig. 4A, B). These results point to the
fact that hypoxia-induced autophagy is crucial for the down-
regulation of proinﬂammatory signaling. Conversely, hypoxia still
reduced the protein expression of NLRP3 in the presence of
chloroquine (Fig. 5c and Supplementary Fig. 4C), indicating that
NLRP3 degradation is not autophagy-mediated.
Hypoxia reduces the binding of NLRP3 and mTOR. Following
our results showing that blockage of autophagy in Il-10−/−mice
was NLRP3-dependent, and that hypoxia reduces NLRP3
expression concomitantly with the activation of autophagy in the
DSS and Il-10−/−mouse models of colitis, as well as cultured IECs,
we sought to determine the role of NLRP3 in the regulation of
autophagy. HT-29 cells transfected with NLRP3-speciﬁc siRNAs
displayed a reduction in mTOR phosphorylation and an
increased basal autophagy as evidenced by the degradation of the
autophagy proteins p62 and LC3 (Fig. 6a and Supplementary
Fig. 5A–D), suggesting that NLRP3 plays a crucial role in the
constitutive blockage of autophagy through the promotion of
mTOR phosphorylation. Moreover, co-immunoprecipitation
(Co-IP) experiments identiﬁed NLRP3 as a direct binding
partner of mTOR and showed that this direct interaction is
reversed under hypoxia in IECs (Fig. 6b and Supplementary
Fig. 5E, F).
DMOG reduces DSS colitis and NLRP3, and promotes
autophagy. To study the role of HIF-1α stabilization in hypoxia-
mediated anti-inﬂammatory effects, WT mice were administered
with 2% DSS for 7 days in drinking water and treated
concomitantly with the hydroxylase inhibitor DMOG. DMOG
activates the HIF pathway by mimicking hypoxia through the
inhibition of hydroxylase activity, leading to stabilization and
transactivation of HIF-1α9. DSS-treated mice receiving DMOG
presented a less severe colitis compared to mice receiving vehicle
as evidenced by a signiﬁcant reduction in body weight (Fig. 7a)
and colonoscopy results (Fig. 7c and d). DMOG-treated mice also
showed a clear trend towards less shortening of the colon
(Fig. 7b). Hematoxyline and eosin (H&E)-stained sections of
distal colon tissue taken from animals treated with DMOG pre-
sented a signiﬁcant lower histological score compared to
phosphate-buffered saline (PBS)-treated mice, and showed intact
crypts in large areas without extensive inﬁltration or thickening of
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the mucosa (Fig. 7d and e). DMOG reduced DSS-induced Tnfα,
Il-6, Il-1β, and Nlrp3 mRNA expression (Figs. 7g–j), and induced
the expression of the autophagy protein p62 (Fig. 7l). These mice
also presented a tendency towards an increase of Lc3 (Fig. 7m).At
protein level, DMOG-treated mice showed reduced NF-κB
phosphorylation and NLRP3 expression, as well as enhanced
autophagy evidenced by the increase of the ratio LC3-II/LC3-I
and degradation of p62, when compared with vehicle-treated
mice (Fig. 7n and Supplementary Fig. 6A–E).
Discussion
Our results show that environmental hypoxia reduces TNFα, IL-6,
and NLRP3 expression concomitantly with the induction of p62
mRNA expression and p62 protein clearance in the colon of
patients with CD, suggesting an increase in autophagy turnover31.
In contrast, biopsies from patients with UC did not display
changes in the expression of inﬂammatory mediators or p62. It is
increasingly recognized that CD and UC constitute distinct
molecular entities32. The discrepancy between patients with CD
and UC might reﬂect the different molecular mechanisms
underlying both pathologies. Interestingly, recent studies have
shown different HIF expression patterns in intestinal biopsies
from patients with UC and CD, suggesting divergent responses to
hypoxia33. The heterogeneity in disease and treatments might
also contribute to the contrasting molecular responses. In line
with the results obtained in patients with CD, prolonged hypoxia
downregulated NF-κB signaling and the expression of Tnfα, Il-6,
and Il-1β in the DSS and Il-10−/−mouse models of colitis. In HT-
29 cells, hypoxia triggered transient accumulation of HIF-1α and
resulted in the reduction of basal and LPS-induced NF-κB and
IκBα phosphorylation. These results are in agreement with recent
reports showing that hypoxia inhibits LPS-induced TNFα and
NF-κB activation in colon epithelial cancer cells34, and conﬁrm
previous studies showing protective effects of hypoxia on mucosal
inﬂammation5, 12, 35. Conversely, several studies suggest that
reduced oxygen levels induce the expression of TNFα and IL-6 in
monocytes and directly activate the NF-κB pathway by blocking
hydroxylation of factors in that pathway36, 37.This discrepancy,
however, might reﬂect that responses to hypoxia differ in
different cell types. Recent studies indicate that aircraft travel-
associated low oxygen partial pressure heightens the risk of ﬂares
in IBD patients4, 38, and altitude-associated hypoxia increases the
expression of inﬂammatory cytokines in the duodenum of healthy
individuals39. Nonetheless, these effects can be due to con-
founding factors such as stress, acute exercise, or local changes in
circulation40, 41. On the other hand, there is mounting evidence
that hypoxia promotes resolution of inﬂammation in several
models of disease5, 13, 42. In transgenic mice, loss of HIF-1α
expression in the epithelium resulted in a more severe colitis,
while constitutively active HIF-1 was protective11, 43, 44.
In line with recent studies linking deﬁcient autophagy with
IBD22, 45, 46, DSS-treated WT mice and Il-10−/− mice presented
accumulation of phosphorylated/activated mTOR, the main
inhibitor of autophagy, and the autophagy protein p62, together
with increased NF-κB phosphorylation and inﬂammatory gene
expression. Hypoxia restored autophagy clearance of p62 redu-
cing mTOR phosphorylation and proinﬂammatory gene expres-
sionand signaling inthese mice. Hypoxia also upregulated p62
mRNA expression, pointing to a compensatory mechanism for
autophagosomal p62 protein degradation. In HT-29 cells,
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hypoxia ameliorated inﬂammatory processes together with the
inactivation of mTOR, and induced degradation of p62 and LC3,
conﬁrming that hypoxia triggers autophagy through the regula-
tion the catalytic activity of mTOR. This is in good agreement
with studies showing that mTOR represses autophagy by phos-
phorylating, and thereby downregulating the autophagy-
associated proteins unc-51-like kinase 1 and ATG1347, 48. The
blockage of autophagy at late stage with chloroquine reverted
hypoxia-mediated inhibition of NF-κB phosphorylation, con-
ﬁrming a causal link between hypoxia-mediated autophagy and
the downregulation of inﬂammation. These results point to an
effect upstream of the NF-κB signaling cascade. In this regard,
several studies show that autophagy inhibits NF-κB activation
through the suppression of the upstream regulatory factor IκB
kinase (IKK)49, and the recruitment of phosphorylated IKK to the
autophagosome compartment50. Hypoxia-mediated inhibition of
NF-κB nuclear translocation is also linked to reduced IKKβ
phosphorylation in colon epithelial cells34. The two main nuclear
factors involved in the regulation of mucosal responses to oxygen
deprivation, NF-κB, and HIF-1α, appear to be intimately linked at
several mechanistic levels6. In line with the signiﬁcant increase of
p62 mRNA expression observed under hypoxia, ChIP analysis in
HT-29 cells showed an increased recruitment of HIF-1α, but not
NF-κB, to the promoter of p62, indicating a role for HIF-1α in the
expression of autophagy proteins. Conversely, NF-κB, but not
HIF-1α, was bound to the NLRP3 promoter under normoxic and
hypoxic conditions. The opposing binding of these nuclear factors
to p62 and NLRP3 promoters suggest a converse transcriptional
regulation of both genes, and appears to align with their antag-
onistic function. After 24 h of hypoxia, we found lysosomal
accumulation in HT-29 cells, but could not detect any effects on
active mitochondria. Since lysosomal formation precedes mito-
chondrial degradation, longer hypoxia periods might be needed
to elicit mitochondria damage and clearance.
Il-10−/− Nlrp3−/− mice did not present blockage of autophagy
under normoxia when compared to Il-10−/− mice, suggesting a
role for NLRP3 in the regulation of autophagy. Interestingly,
hypoxia downregulated NLRP3 concomitantly with the induction
of autophagy in the DSS and Il-10−/− mouse models of colitis,
suggesting a role for NLRP3 in hypoxia-induced autophagy.
These results were conﬁrmed in HT-29 cells, where hypoxia
triggered NLRP3 clearance in a proteasome-independent manner.
In contrast to reports showing that autophagy regulates NLRP3
inﬂammasome function through the autophagosomal degrada-
tion of NLRP330, hypoxia-mediated NLRP3 clearance appears to
be autophagy-independent, pointing to differential regulatory
mechanisms for NLRP3 inﬂammasome-dependent and -inde-
pendent effects. siRNA-mediated silencing of NLRP3 in HT-29
cells further promoted autophagy clearance of p62 and LC3,
conﬁrming a role for NLRP3 in the inhibition of autophagy and
reinforcing the idea that NLRP3 degradation precedes and trig-
gers autophagy activation. NLRP3 silencing also reduced the
Inflammation 
NLRP3mTORP
LC3-I
p62
p62
p62
LC3-I
LC3-I
Autophagy
blockage
p50 p65
Inflammatory
stimuli
mTOR NLRP3
Hypoxia
IκBα IκBα
p50 p65
P
P
p50 p65
P
Inflammatory
stimuli
Autophagy
activation
LC3-II
p62
LC3-II p62
LC3-II
p62
HIF-1α
HIF-1α
Pro-inflammatory
gene expression
p62
Mucosal homeostasis
Fig. 8 Hypoxia ameliorates inﬂammation through the activation of autophagy via downregulation of NLRP3/mTOR. Under conditions of inﬂammation,
NLRP3 directly binds and promotes the phosphorylation/activation of the autophagy inhibitor mTOR, thereby blocking autophagy. As a result,
autophagosomal clearance of pro-inﬂammatory mediators is impaired, leading to the perpetuation of inﬂammation. Hypoxia-mediated HIF-1α accumulation
induces the expression of p62, and the reduction of NLRP3 protein levels, thereby downregulating mTOR phosphorylation. Subsequent autophagy
activation leads to autophagosomal degradation of pro-inﬂammatory mediators upstream of the NF-κB signalling cascade, leading to reduced
proinﬂammatory gene expression
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00213-3 ARTICLE
NATURE COMMUNICATIONS |8:  98 |DOI: 10.1038/s41467-017-00213-3 |www.nature.com/naturecommunications 9
levels of phosphorylated mTOR, indicating that NLRP3 regulates
autophagy upstream of the mTOR signaling pathway. Further-
more, Co-IP experiments identiﬁed NLRP3 as a novel binding
partner of mTOR. Our results point to that hypoxia-mediated
NLRP3 clearance reduces the physical interaction between
NLRP3 and mTOR, suggesting that the interaction of both factors
is required for mTOR function and subsequent repression of
autophagy under normoxia. Inﬂammasome-independent effects
for NLRP3 have been increasingly recognized, and recent
research has revealed functions for NLRP3 that do not require the
assembly of the inﬂammasome complex, including the upstream
regulation of transforming growth factorβ/Smad signaling51, 52. It
is well stablished that the catalitic activity of mTOR is tightly
regulated by its physical interaction with mTOR complex-binding
partners. For example, Raptor regulates mTOR activity by
orchestrating the assembly of the mTOR complex and recruiting
substrates for mTOR53, 54. Hypoxia has been proposed to inhibit
mTOR through the regulation of proteins that interfere with its
binding with RHEB. Thus, PML protein binds mTOR during
hypoxia and inactivate it through the secuestration in nuclear
bodies23. Likewise, the hypoxia-inducible factor BNIP3 inhibits
mTOR activation by interacting with RHEB55. Our results suggest
that hypoxia-mediated NLRP3 degradation not only counteracts
mTOR activation, but might also limit NLRP3 inﬂammasome-
dependent responses trigered by danger signals such as ATP24.
Notably, hypoxia has been recently discovered to contribute to
the control of inﬂammation, promoting the phosphohydrolysis of
extracellular ATP, thereby preventing purinergic signaling56.
The ﬁnding that hypoxia might promote the resolution of
inﬂammation has sparked the interest in the therapeutic use of
hydroxylase inhibitors to stabilize HIF for the treatment of IBD.
Thus, the hydroxilase inhibitors AKB-4924 and DMOG are
protective in the DSS and trinitrobenzene sulfonid acid mouse
models of colitis12, 43. Our results indicate that DMOG amelio-
rates DSS colitis and signiﬁcantly reduces inﬂammatory gene
expression and signaling. Interestingly, HIF-1α stabilization
triggered clearance of NLRP3 and p62, and the conversion of
LC3-I to LC3-II. These results conﬁrm our ﬁndings in the DSS
and Il-10−/− mouse models of colitis, and highlight the important
contribution of HIF-1α to hypoxia-mediated autophagy. Recent
research has underscored the importance of HIF signaling in
controlling inﬂammatory and innate host defense responses57.
For example, bacteria- and LPS-mediated induction of HIF-1α
has been demonstrated through an oxygen-independent
mechanism in myloid and colonic epithelial cells58–60.
Consequently, manipulating HIF levels has been considered in
the context of cancer therapy61, infectious diseases, and chronic
inﬂammatory conditions such as rheumatoid arthritis and IBD62.
In summary, our results identify NLRP3 as a binding partner of
mTOR and support a novel role for NLRP3 in the regulation of
hypoxia-mediated anti-inﬂammatory effects through NLRP3
clearance, and subsequent autophagy activation and reduction of
inﬂammatory processes in IECs (Fig. 8). Hypoxia-mediated
NLRP3 degradation not only prevents stimulatory effects on
mTOR signaling but might also limit NLRP3 inﬂammasome-
dependent responses.
Methods
Human subjects. Healthy subjects (n= 10), patients with CD (n= 11) and patients
with UC (n= 9) in stable remission, were subjected to hypoxic conditions
resembling an altitude of 4000 m.a.s.l. for 3 h using a hypobaric pressure chamber
at the Swiss aeromedical center in Dubendorf, Switzerland (ClinicalTrials.gov
number, NCT02849821)63. Clinical activity in patients with CD and patients with
UC was assessed using the Harvey Bradshaw Index and the Partial Mayo Score,
respectively. The participant characteristics are shown in Table 1. Distal colon
biopsies were taken the day before entering the hypobaric chamber, immediately
after hypoxia, and 1 week after collection of the ﬁrst biopsy at the Division of
Gastroenterology and Hepatology of the University Hospital Zurich. This study
was approved by the Ethics Committee of the Canton of Zurich (KEK-ZH Nr.
2013-0284) and all participants signed an informed consent.
Immunohistochemistry. Intestinal specimens from the distal third of the colon
were embedded in parafﬁn and cut in 5 µm sections with a microtome. Immu-
nostaining for p62 was performed on Leica Bond Max instruments using Reﬁne
HRP-Kits (Leica Biosystems, Newcastle, UK). Parafﬁn-embedded tissue was pre-
treated for 20 min at 100 °C with citrate-based buffer at pH 6.0 (Leica Biosystems)
prior to the incubation with p62 monoclonal antibody (Cat. No. GP62-C; PRO-
GEN Biotechnik, Heidelberg, Germany) at a 1:750 dilution. Rabbit anti-Guinea pig
(Cat. No. P0141; Dako, Glostrup, Denmark) was used as a secondary antibody at a
1:100 dilution. Immunohistochemistry score was determined by two independent,
blinded investigators who assigned score values according to the prevalence of
p62 staining (<10% positive cells= 0, 10–25% = 1, 25–50%= 2, 50–75%= 3, and
75–100% = 4)64.
Mouse experiments. Female WT (C57BL/6J) and Nlrp3−/− mice between
8–10 weeks of age were exposed to 2% DSS65 (MP Biomedicals) in drinking water
ad libitum for 7days. Intestinal inﬂammation was induced in WT, Il-10−/−, Nlrp3
−/−, and Il-10−/−Nlrp3−/− mice by oral administration of 1.5% DSS in drinking
water ad libitum for 5 days66, 67. Mice were separated into hypoxia and normoxia
groups. The hypoxia group was exposed to hypoxia (8% O2) in a normobaric
hypoxic chamber (Coy Laboratory Products, Grass Lake, MI), whereas the nor-
moxia group (21% O2) was used as control. After 18 h of hypoxia, mice were killed
for colonic biopsy collection. WT mice were exposed to 2% DSS in drinking water
ad libitum for 5 days and were co-administered with 8 mg DMOG (Frontier Sci-
entiﬁc, Logan, UT) dissolved in PBS, injected intraperitoneally every second day12.
Control mice received PBS. After a recovery period, mice were killed at day 9 and
Table 1 Participant characteristics
HV CD UC
Item
Number of patients 10 11 9
Gender, females 3 (30%) 6 (54.5%) 5 (55.6%)
Age (mean± SD) 28.2± 4.9 35.2± 13.3 31.8± 10.8
Age in males (mean± SD) 29± 5.5 41.3± 16 30± 4.7
Age in females (mean± SD) 26.3± 3.2 29± 6.4 33.2± 14.5
Smoking status 2/10 (20.0%) 3/11 (27.3%) 2/9 (22.2%)
Disease severity
Harvey-Bradshaw Index for CD patients (median, IQR) NA 0.0 NA
Partielle Mayo Score for UC patients (median, IQR) NA NA 0.0
Medical history
Azathioprine / 6-MP NA 5/11 (45.5%) 7/9 (58.3%)
Methotrexate NA 1/11 (9.1%) 0
Anti-TNF NA 6/11 (54.5%) 2/9 (16.7%)
Systemic steroids NA 1/11 (9.1%) 3/9 (25.0%)
NSAID intake NA 2/11 (18.2%) 6/9 (75.0%)
CD Crohn’s disease, HV Healthy volunteers, UC ulcerative colitis, SD standard deviation, NA not applicable
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distal colon biopsies were taken. Ethical approval for all animal experiments was
obtained by the University of Zurich from the Veterinary Ofﬁce of the Canton of
Zurich, Switzerland.
Colonoscopy and determination of histological score. Animals were anesthe-
tized intraperitoneally with a mixture of ketamine 90–120 mg/kg body weight
(Vétoquinol) and xylazine 8 mg/kg body weight (Bayer), and colonoscopy was
performed using the Coloview miniendoscopic system (Karl Storz, Tuttlingen,
Germany)68. Animals were killed and 1 cm of tissue was removed from the distal
third of the colon and ﬁxed in 4% formalin overnight. H&E-stained sections of the
parafﬁn-embedded tissue were used for histological analysis. Histological score was
calculated as the sum of epithelial damage and inﬁltration score69, and was
determined by two independent, blinded investigators.
RNA isolation and real-time quantitative PCR (RT-qPCR). Colonic biopsies
were disrupted using the GentleMACS Dissociator (Miltenyi Biotech, Gladbach,
Germany). Total RNA from human and mice biopsies, and cells was extracted
using RNeasy Plus Kit (Qiagen, Hombrechtikon, Switzerland) according to man-
ufacturer’s instructions. For reverse transcription, the High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Foster City, CA) was used fol-
lowing the manufacturer’s instructions. RT-qPCR was performed using the Taq-
Man system 7900HT (Applied Biosystems), under the following cycling conditions:
20 s at 95 °C, followed by 40 cycles of 95 °C for 3 s, and 60 °C for 30 s with the
TaqMan Fast Universal Mastermix. TaqMan Gene Expression Assays (all from
Applied Biosystems) used in this study were human TNF (Hs00174128_m1), IL1B
(Hs01555410_m1), IL6 (Hs00174131_m1), NLRP3 (Hs00918082_m1), p62
(SQSTM1) (Hs01061917_g1), LC3 (MAP1LC3A) (Hs01076567_g1) and β-actin
Vic TAMRA (4310881E), and mouse Tnf (Mm99999068_m1), Il1b
(Mm00434228_m1), Il6 (Mm00446190_m1), Nlrp3 (Mm00840904_m1), Vegfa
(Mm00437306_m1), p62 (Sqstm1) (Mm00448091_m1), Lc3 (Map1lc3a)
(Mm00458724_m1) and β-actin VIC TAMRA (4352341E). Relative mRNA
expression was calculated by the comparative ΔΔCt method using β-actin as
housekeeping gene.
Western blotting and Co-IP. Total protein from biopsies and cells was collected in
M-PER lysis buffer (Thermo Fisher Scientiﬁc, Reinach, Switzerland). Phospho-p65/
RelA (Ser536, 93H1) (Cat. No. 3033), p65/RelA (D14E12) (Cat. No. 8242),
phospho-mTOR (Ser2448) (Cat. No. 2971), mTOR (7C10) (Cat. No. 2983), p62
(Cat. No. 5114), phospho-IκBα (Ser32, 14D4) (Cat. No. 2859), IκBα (Cat. No.
9242), ubiquitin (Cat. No. 3933) (Cell Signaling Technology, ZA Leiden, The
Netherlands), anti-mouse NLRP3 (Cat. No. AG-20B-0014-C100; AdipoGen, Lies-
tal, Switzerland), anti-mouse HIF-1α (EP1215Y) (Cat. No. ab51608; Abcam,
Cambridge, UK), anti-human HIF-1α (Cat. No. NB100-479; Novus Biologicals,
Littletown, CO), anti human NLRP3 (Cat. No. ALX-804-819-C100; Enzo Life
Sciences, Lausen, Switzerland), LC3 (Cat. No. L8919) and β-actin (Cat. No. A5441)
(Sigma-Aldrich, St Louis, MO) antibodies were used at 1:1000 dilution for western
blot. Co-IP was performed overnight at 4 °C using the human NLRP3 antibody at
1:100 dilution. Immunocomplexes were collected with protein G sepharose beads
(GE Healthcare, Glattburgg, Switzerland) for 1 h at 4 °C prior to Western blotting.
Densitometry of bands was measured using ImageJ software.
Cell culture and hypoxia treatment. HT-29 cells were obtained from the German
Collection of Cells and Microorganisms (DSMZ, Braunschweig, Germany), and
cultured in DMEM medium supplemented with 10% FCS (VWR, Dietikon,
Switzerland). In some experiments, HT-29 cells were treated with 10 µg/ml LPS
(Invitrogen, Carlsbad, CA). Late-stage autophagy was inhibited with 40 µM
chloroquine (Sigma-Aldrich) for 1 h prior to hypoxia. Proteasomal activity was
inhibited with 20 µM MG132 (Sigma-Aldrich) for 1 h prior to 24 h hypoxia. Cells
were exposed to hypoxia (0.2% O2) in a hypoxia workstation incubator (In vivo
400, Baker Ruskinn, Bridgend, UK). Cells maintained in normoxia (21% O2) for
the same time-period were used as controls.
Confocal microscopy. After 24 h under normoxia or hypoxia, HT-29 cells were
stained with LysoTracker Yellow-HCK-123 and MitoTracker Deep Red FM
(Thermo Fisher Scientiﬁc) according to manufacturer’s instructions. For
LC3 staining, HT-29 cells subjected to normoxia or hypoxia for 24 h were ﬁxed
with 4% paraformaldehyde for 20 min and then permeabilized in 100% methanol.
After blocking with 3% bovine serum albumin, cells were incubated with LC3
antibody (Cat. No. PM036; MBLI, Woburn, MA) at 1:200 dilution overnight at
4 °C. Cells were then incubated with Alexa 488 conjugated secondary rabbit
antibody (Invitrogen) for 1 h and DAPI for 5 min before mounting with antifade
medium (Dako). Cells were analysed by a Leica SP5 laser scanning confocal
microscope (Leica Microsystems, Wetzlar, Germany). Fluorescence images of the
same sample were acquired and processed using Leica confocal software (LAS-AF
Lite; Leica Microsystems). Quantiﬁcation of LC3/DAPI was performed by two
independent, blinded investigators using ImageJ software in at least tenareas of
interest pooled from four independent experiments.
Small interfering (siRNA) transfection. HT-29 cells were transfected with 10
pmol of three sets of siRNAs for NLRP3 (Life Technologies) using Lipofectamine
RNAiMAX (Invitrogen) according to the manufacturer’s instructions.
ChIP analysis. ChIP was performed using the ChIP-IT Express Enzymatic kit
(Active Motif, Carlsbad, CA) according to the manufacturer’s instructions.
Immunoprecipitation of 25 µg of DNA was carried out overnight at 4 °C using anti-
HIF-1α (Cat. No. NB100-479; Novus biologicals, Littletown, CO) or anti-p65/RelA
(D14E12) (Cat. No. 8242; Cell Signaling Technology) antibodies at a concentration
of 1 μg/ml. DNA isolated from an aliquot of the total nuclear extract was used as a
loading control for the PCR (input control). PCR was performed with total DNA
and immunoprecipitated DNA using the following promoter-speciﬁc primers, p62
promoter-binding site for HIF-1α: 5′-ATCCCGATCGGCTCCCG-3′ (forward), 5′-
ACTCCCACTCCAGCCTTACC-3′ (reverse) (70 bp), and NF-κB: 5′-
ACTGGGCGGTTGAAGCC-3′ (forward), 5′-TCCAGAGGCCCAGAGGAAG-3′
(reverse) (87 bp), NLRP3 promoter-binding site for HIF-1α: 5′-
TTCTTCTGGCGTCTCCAAGG-3′ (forward), 5′-TTGCACACGTA-
GAGCCCAAA-3′ (reverse) (81 bp), and NF-κB: 5′-CCAGTATGGAACCGAGA-
CACG-3′ (forward), 5′-CAGAGCAGAGGCAGAGAGACT-3′ (reverse) (97 bp).
The PCR products (10 µl) were subjected to electrophoresis on a 2% agarose gel.
Statistics. Statistical analysis was performed using Student t test, or one-way
ANOVA followed by Tukey’s post-test. The results are expressed as mean +
standard error of the mean (s.e.m.) and signiﬁcance was set as p< 0.05.
Data availability. The authors declare that all the data supporting the ﬁndings of
this study are available in the manuscript or are available from the corresponding
author upon reasonable request.
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